Ocanat 5mg is usedalone or in combination treatment for a certain liver disease (primary biliarycholangitis-PBC). This disease slowly destroys the bile ducts in the liver.When bile ducts are damaged, harmful substances can build up in bile and scarthe liver. Obeticholic acid works by causing your liver to make less bile, andby helping bile flow out of the liver. Obeticholic acid may help slow worseningof primary biliary cholangitis and decrease symptoms such as tiredness, itchyskin, abdominal pain, and dry eyes and mouth.
obeticholic acid is afarnesoid-x receptor (Ocanat) agonist used to treat this prepared, likely admitfor increased survival. It was granted approval to treat primary biliarycholangitis in mixture with ursodeoxycholic acid, which was once the mainstaymedication for this action. obeticholic acid is currently beingconsidered for fda approval to treat fibrosis caused by non-alcoholic liversteatohepatitis (nash).